Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOT-NSTI: Adjunctive Hyperbaric Oxygen Treatment for Necrotizing Soft-Tissue Infection
NCT07489274Phase 4Recruiting
- Sponsor
- Ole Hyldegaard
- Start
- Apr 2026
- Primary completion
- Apr 2033
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 2
01
Overview
A Phase 4 trial of hyperbaric oxygen therapy in necrotizing soft tissue infection (NSTI), sponsored by Ole Hyldegaard. Started Apr 2026; status: recruiting.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
necrotizing soft tissue infection (NSTI)
Beyond the preview
Go deeper on NCT07489274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07489274.